NCI / SPORE Program
Gateway is partnering with the NCI to give SPORE recipients the opportunity to apply for supplemental funding for their early phase, innovative clinical trials. The Gateway funding could enable principal investigators and their respective institutions to start a new trial by adding an additional arm, add patient cohorts and/or new correlative analysis. Funding cannot duplicate scope of work of the SPORE award.
Grants are generally awarded for a 2-5 year period, with total award amounts generally ranging from $200,000 to $800,000.
GFCR Grant Program
These core grants fund early phase clinical trials for cancers of all types at renowned institutions around the world. Grants are typically 2-5 years in duration with award amounts from $200,000 to $1.5 million.
GFCR Integrative Program
Gateway is focused on funding integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life, especially post-treatment. Grants are generally awarded for a 2-5 year period, with total award amounts generally ranging from $200,000 to $1.5 million.
SIO Integrative Program
Gateway is focused on funding integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life, especially post-treatment. Grants are generally awarded for a 2-5 year period, with total award amounts generally ranging from $200,000 to $1.5 million.